Besides, GATA2 is a pioneer transcription factor for androgen receptor (AR) in prostate cancer, and increased GATA2 and its AR-independent transactivation of IGF2 could mediate taxane resistance through the activation of IGF1/insulin receptor signaling [34]. The gene discussed is GATA2; the disease is prostate carcinoma.